Push up stock price failure

The share price of Chongqing beer (600132, closing at 65.03 Yuan) has unexpectedly fallen sharply, just after the announcement of a 12.25% per cent share of Carlsberg's group of Ka-won beers approved by the Ministry of Commerce. Yesterday (December 6), Chongqing, the sudden volume of beer fell, the plate almost did not see a strong rebound, the close before the closing is again fell, and finally ended with a 9.34% close, a deal 8.407 million shares, compared to the last Friday 3.0866 million shares magnified more than one times.　　Chongqing Beer became the first big drop in Shanghai stock yesterday. The biggest increase in the year was as high as 240% compared to Tsingtao beer, yanjing beer companies, Chongqing beer growth is very limited.　　According to the data disclosed in the third quarterly report, Chongqing Beer in the first three quarters to achieve operating income of 1,934,320,000 yuan, an increase of 2.86%, to achieve a net profit of 155.85 million yuan, the year-on-year increase of 7.89%.　　and the main business of beer, is not the main force of the fried Chongqing beer value. "Many private and even public offering funds are looking forward to the company's treatment with hepatitis B vaccine, which is the most important factor in the price of Chongqing beer in this year's fry."　　"A private-equity official told the Daily Economic news reporter. This year, Chongqing Beer has released a series of recent advances in the treatment of hepatitis B vaccine, which directly contributed to the rise in share prices. At the end of 2009, the price of Chongqing beer was still 23.52 yuan, but to November this year, its share price reached 79.98 yuan, the biggest rise in the year up to 240.05%.　　Although the recent stock price correction, the rise is still as high as 176.49%!　　According to the daily economic news, since June this year, Chongqing Beer released the "treatment (synthetic peptide) hepatitis B vaccine" Progress bulletin, each month will be announced at the beginning of a monthly bulletin, so far has issued 7 relevant announcements. In the meantime, brokerage analysts also helped to become a big driver of the stock price rise.　　For example, Societe Generale Securities, since September 2, has issued a series of 7 reports on the Chongqing beer, each time is given a "strongly recommended" rating.　　However, since the fall of November 17, the industrial securities of the comments have been not the spirit, the stock price fell continuously, and yesterday to create a November-year closing low.　　The private-equity figures said although published every month, but the bulletin did not give a description of the clinical effect of hepatitis B vaccine, this may also make the market for Chongqing Beer produced aesthetic fatigue, after all, short-term valuation is too high, and the future can be successful development, there are still large uncertainties.　　There are also analysts said that this year, Chongqing Beer's rise is huge, and big into the fund heavy warehouse latent, so the current stock price is difficult to attract new funds to continue to sedan chair.　　The agency yesterday slashed "daily economic news" from the Chongqing beer Seat transaction information found that institutions joined the selling ranks, and sold much more than the purchase volume. Of the top 5 seats sold, the sale amount is more than 10 million yuan, of which two are institutional seats, sold 33,790,940 and 1322.0 respectively8.39 million Yuan.　　It is also the first time in more than half a year that institutional seats have appeared on the sell seats. and sell the largest Wanguo securities Fujian Xiamen Xiahe Sales Department, the amount of up to 53,178,515 yuan.　　The sales department yesterday sold about 800,000 shares of Chongqing beer, according to the average price of 67.03 yuan sold yesterday.　　In addition, Everbright Securities Chengdu Wu Cheng Street Sales department and Shanghai Securities Nanjing set Huai Door Street Sales department sold 16,587,119 Yuan and 12,062,417 yuan respectively, sold more than 10 million yuan.　　From the purchase of the top 5 seats to look relatively small, buy the largest wealth of the financial pass Hangzhou Huan Cheng West Road Sales department to buy the amount of 20,050,820 yuan, while the other 4 seats of the purchase amount of less than tens of millions of dollars. A senior market personage said that, the first 5 big buy seats of the volume is obviously small, indicating that the main capital of Chongqing beer, is gradually retreat, this from Chongqing beer in recent period of the trend is evident. Earlier on November 17, Chongqing Beer had a fall, after a reluctant rebound, but yesterday on the technical surface has formed a break, there is the possibility of forming a medium-term head. And Chongqing beer is in the continuous release of hepatitis B vaccine progress, as well as Carlsberg acquisition and other good news, still fell sharply, indicating that the fall is likely to be the monthly line level correction.